Clinical data in early intervention

International Psychogeriatrics

Volumn 24, Issue SUPPL. 1, 2012, Pages

  Kasper, Siegfried ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

adherence; Alzheimer's disease; attention; clinical studies; cohort studies; dementia; epidemiological studies; memory; safety

Indexed keywords

GINKGO BILOBA EXTRACT;

ALZHEIMER DISEASE; ARTICLE; ATTENTION; CLINICAL STUDY; COHORT ANALYSIS; CONFIDENCE INTERVAL; DEATH; DEMENTIA; DISEASE COURSE; DOUBLE BLIND PROCEDURE; EARLY INTERVENTION; HAZARD RATIO; HUMAN; INCIDENCE; MEMORY; MILD COGNITIVE IMPAIRMENT; MORTALITY; MULTICENTER STUDY (TOPIC); NEUROPSYCHOLOGY; OSTEOPOROSIS; PATHOLOGY; PATIENT COMPLIANCE; PROSPECTIVE STUDY; RISK FACTOR; SURVIVAL; TREATMENT DURATION;

ALZHEIMER DISEASE; COGNITION; EARLY DIAGNOSIS; GINKGO BILOBA; HUMANS; MEDICATION ADHERENCE; MILD COGNITIVE IMPAIRMENT; NOOTROPIC AGENTS; PHYTOTHERAPY; PLANT EXTRACTS;

EID: 84863980276     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610212000555     Document Type: Article

References (15)

1. Andrieu, S. et al. (2003). Association of Alzheimer's disease onset with Ginkgo biloba and other symptomatic cognitive treatments in a population of women aged 75 years and older from the EPIDOS study. Journals of Gerontology, 58, 372-377.
2. Andrieu, S., Ousset, P. J., Coley, N., Ouzid, M., Mathiex-Fortunet, H. and Vellas, B. (2008). GuidAge study: a 5-year double blind, randomised trial of EGb 761 for the prevention of Alzheimer's disease in elderly subjects with memory complaints. I. Rationale, design and baseline data. Current Alzheimer Research, 5, 406-415.
3. Dartigues, J. F., Carcaillon, L., Helmer, C, Lechevallier, N., Lafuma, A. and Khoshnood, B. (2007). Vasodilators and nootropics as predictors of dementia and mortality in the PAQUID cohort. Journal of the American Geriatrics Society, 55, 395-399.
4. DeKosky, S. T. et al. (2008). Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA, 300, 2253-2262.
5. Dodge, H. H., Zitzelberger, T., Oken, B. S., Howieson, D. and Kaye, J. (2008). A randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline. Neurology, 70, 1809-1817.
6. Grass-Kapanke, B., Busmane, A., Lasmanis, A., Hoerr, R. and Kaschel, R. (2011). Effects of Ginkgo biloba special extract EGb 761® in very mild cognitive impairment (vMCI). Neuroscience & Medicine, 2, 48-56.
7. Hampel, H. et al. (2011). Biomarkers for Alzheimer's disease therapeutic trials. Progress in Neurobiology, 95, 579-593
8. Ihl, R., Frölich, L., Winblad, B., Schneider, L., Burns, A. and Möller, H. J. on behalf of the WFSBP Task Force on Treatment Guidelines for Alzheimer's Disease and other dementias (2011). World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of Alzheimer's disease and other dementias. World Journal of Biological Psychiatry, 12,2-32.
9. Jack, C. R. Jr. et al. (2010). Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurology, 9, 119-128.
10. Jerant, A., Chapman, B., Duberstein, P., Robbins, J. and Franks, P. (2011). Personality and medication non-adherence among older adults enrolled in a six-year trial. British Journal of Health Psychology, 16, 151-169.
11. Kaschel, R. (2009). Ginkgo biloba: specificity of neuropsychological improvement-a selective review in search of differential effects. Human Psychopharmacology, 24, 345-370.
12. Kasper, S. and Schubert, H. (2009). Ginkgo-Spezialextrakt EGb 761® in der Behandlung der Demenz: Evidenz für Wirksamkeit und Verträglichkeit. Fortschritte der Neurologie-Psychiatrie, 77, 1-12.
13. Snitz, B. E. et al. (2009). Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial. JAMA, 302, 2663-2670.
14. Vellas, B. et al. for the GuidAge Study Group (2010). Results of GuidAge: a 5-year placebo-controlled study on the efficacy of EGb 761 120 mg to prevent or delay Alzheimer's dementia onset in elderly subjects with memory complaint. Journal of Nutrition, Health & Aging, 14 (Suppl. 2), S23.
15. Vellas, B. et al. (2011). Prevention trials in Alzheimer's disease: an EU-US Task Force report. Progress in Neurobiology, 95, 594-600.